Merck & Company Inc. (MRK) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Merck & Company Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$140.93
−0.63% today
Market cap
$349.9B
Overall quality
—
Kronos AI 30-day
−6.0%
1 of 8 simulated paths end higher
Merck & Company Inc. (MRK) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $349.9B. It trades at $140.93, down 0.63% today. 21 analysts' average target of $161.19 implies +14.4% from today's price. Kronos AI's 30-day forecast is −6.0% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $161.19 |
| Low – high | $105.00 – $180.00 |
| Analysts | 21 |
| Upside to average | +14.4% |
Kronos AI 30-day forecast
| Expected close | $133.28 (−6.0%) |
| Likely range | −8.2% … −0.8% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.